相关实验视频
Updated: Jul 2, 2025
04:23
The Creation of a Rat Model for Osteosarcopenia via Ovariectomy
Published on: February 21, 2025
313
免疫性血小板缺血及其治疗是否与萨尔科佩尼亚有关?
1Obesity Department, Dr. Lutfi Kırdar Kartal City Hospital, Kartal, Istanbul/Turkey.
Nigerian journal of clinical practice
|February 26, 2024
概括
一种肌肉疾病的sarcopenia可能更常见于免疫性血栓塞缩症 (ITP) 患者. 低肌肉质量是普遍存在的,但eltrombopag治疗显示了ITP肌肉健康的潜在益处.
科学领域:
- 血液学 血液学 血液学
- 老年病的医生 老年病的医生
- 肌肉骨科学 肌肉骨科学
背景情况:
- 免疫性血小板缺血 (ITP) 具有低血小板计数的特征,没有其他原因.
- 萨科佩尼亚是一种渐进的肌肉疾病,导致运动能力和生活质量下降.
研究的目的:
- 为了确定ITP患者的肉类的频率.
- 调查ITP疗法对肉症的潜在影响.
主要方法:
- 对53名ITP患者的前性研究,不包括最近使用的皮质类固醇.
- 评估的肌肉力量,尾骨肌肉质量 (ASMM),ASMM/身高2,软肌肉质量 (SLM) 和6分钟的步行速度.
主要成果:
- 13.21%的人确诊患有肉,9.43%可能患有肉;没有人患有严重的肉.
- 肌肉力量损失在22.64%;低SLM在92.45%和低干SLM (SLMT) 在54.72%.
结论:
- 麻症在ITP患者中可能比一般人群中更频繁.
- 低肌肉质量 (SLM,SLMT) 在ITP中非常普遍.
- 埃尔特伦博巴格治疗可能对ITP患者的肌肉质量和力量产生积极影响.
相关概念视频
01:27Tumor Immunotherapy
524
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
524
03:03mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
01:01Regulation of Hematopoietic Stem Cells
3.2K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.2K